Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-07-14
2008-11-25
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600
Reexamination Certificate
active
07456151
ABSTRACT:
The present invention provides methods and compositions for modulating proliferation, differentiation, migration, and adhesion of cardiovascular cell types.
REFERENCES:
patent: 5747262 (1998-05-01), Hinck et al.
patent: 5824775 (1998-10-01), Swimmer et al.
patent: 5939271 (1999-08-01), Tessier-Lavigne et al.
patent: 6017714 (2000-01-01), Tessier-Lavigne et al.
patent: 6028173 (2000-02-01), Landes et al.
patent: 6030806 (2000-02-01), Landes et al.
patent: 6087326 (2000-07-01), Hinck et al.
patent: 6096866 (2000-08-01), Tessier-Lavigne et al.
patent: 6218526 (2001-04-01), Swimmer et al.
patent: 6277585 (2001-08-01), Tessier-Lavigne et al.
patent: 6309638 (2001-10-01), Tessier-Lavigne et al.
patent: 6428965 (2002-08-01), Ginty et al.
patent: 6448054 (2002-09-01), Poznansky et al.
patent: 6495674 (2002-12-01), Lemke et al.
patent: 6566094 (2003-05-01), Kimura et al.
patent: 2003/0040046 (2003-02-01), Tessier-Lavigne et al.
patent: 2003/0049248 (2003-03-01), Tessier-Lavigne et al.
patent: 2003/0207347 (2003-11-01), Olson et al.
patent: 2004/0003163 (2004-01-01), Kleveland et al.
patent: WO-95/13367 (1995-05-01), None
patent: WO-97/14424 (1997-04-01), None
patent: WO-97/40064 (1997-10-01), None
patent: WO-98/37085 (1998-08-01), None
patent: WO-00/32746 (2000-06-01), None
patent: WO-00/53735 (2000-09-01), None
patent: WO-01/64837 (2001-09-01), None
patent: WO-02/33080 (2002-04-01), None
Borisy et al. (2003). Systematic discovery of multicomponent therapeutics. Proc. Natl. Acad. Sci. USA. 100(13):7977-7982.
Nico et al. (2001). Vascular stem cells and angiogenesis. Journal of Hematotherapy & Stem Cell Research. 10:905-912.
Park et al. (2005). Identification of new netrin family members in zebrafish: developmental expression of netrin2 and netrin4. Developmental Dynamics. 234:726-731.
Püschel, A.W. (1999). Divergent properties of mouse netrins. Mechanisms of Development. 83:65-75.
Park et al. (2004). The axonal attractant netrin-1 is an angiogenic factor. Proc. Natl. Acad. Sci. USA. 101(46):16210-16215.
Wells, J.A. (1990). Additivity of mutational effects in proteins. Biochemistry. 29(37):8509-8517.
Ngo et al. (1994). Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) The Protein Folding Problem and Tertiary Structure Prediction. Birkhauser:Boston, pp. 491-495.
Skolnick et al. (2000). From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech. 18(1):34-39.
Corset, V., et al., “Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor,”Nature, 407:747-750 (2000).
Culotti, J.G., and Merz, D.C., “DCC and netrins,”Curr Opin Cell Biol, 10:609-613 (1996).
Dickson, Barry J., “Molecular Mechanisims of Axon Guidance”, Science, 298(5600), pp. 1959-1964 (2002) Abstract.
Dubey, R.K., et al., “A2BAdenosine Receptors Stimulate Growth of Porcine and Rat Arterial Endothelial Cells,”Hypertension, 39:530-535 (2002).
Folkman, J., and D'Amore, P.A., “Blood Vessel Formation: What Is Its Molecular Basis?”Cell, 87:1153-1155 (1996).
Huber, A.B., et al., “Signaling at the Growth Cone: Ligand-Receptor Complexes and the Control of Axon Growth and Guidance,”Annu. Rev. Neurosci., 26:509-563 (2003).
Keleman, K., and Dickson, B.J., “Short- and Long-Range Repulsion by theDrosophila Unc5 Netrin Receptor,”Neuron, 32:605-617 (2001).
Kusano, K.F., et al., “Sonic Hedgehog Induces Arteriogenesis in Diabetic Vasa Nervorum and Restores Function in Diabetic Neuropathy,”Arterioscler Thromb Vasc Biol, 24:2102-2107 (2004).
Lu, X., et al., “The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system”,Nature, 432 (7014), pp. 179-186 (2004).
Nakashiba, T., et al., “Complementary expression and neurite outgrowth activity of netrin-G subfamily members,”Mechanisms of Development, 111:47-60 (2002).
Nakashiba, T., et al., “Netrin-G1: a Novel Glycosyl Phosphatidylinositol-Linked Mammalian Netrin That Is Functionally Divergent from Classical Netrins,”Journal of Neuroscience, 20(17):6540-6550 (2000).
Park, K.W., et al., “The axonal attractant Netrin-1 is an angionenic factor”,Proceedings of the National Academy of Sciences of the United States of America, 101(46), pp. 16210-16215 (2004).
Tessier-Lavigne, M. and Goodman, C. S., “The Molecular Biology of Axon Guidance”, Science, 274:1123-1133 (1996) Abstract.
Thiebault, K. et al., “The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment”,Proceedings of the National Academy of Sciences of USA, National Academy of Science, 100(7), pp. 4173-4178 (2003).
Weinstein, B.M., “Vessels and Nerves: Marching to the Same Tune,”Cell, 120:299-302 (2005).
Yin, Y., et al., “Identification and expression of mouse netrin-4,”Mechanisms of Development, 96:115-119 (2000).
Li Dean Y.
Park Kye Won
Lockard Jon M
Saoud Christine J
Stoel Rives LLP
University of Utah Research Foundation
Webb Samuel E.
LandOfFree
Promoting angiogenesis with netrin1 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promoting angiogenesis with netrin1 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promoting angiogenesis with netrin1 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4043000